GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Optimer Pharmaceuticals, Inc. (OPTR) [hlAlert]

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. The Company?s development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. It has two late-stage anti-infective product
candidates: fidaxomicin (formerly OPT-80) and prulifloxacin. Fidaxomicin, the Company?s lead product candidate, is an antibiotic in its second Phase III registration trial for the treatment of Clostridium difficile-infections (CDI), the common nosocomial, or hospital acquired diarrhea. Prulifloxacin is a prodrug in the fluoroquinolone class of antibiotics. The Company is developing additional product candidates using its technology, including its Optimer One-Pot Synthesis (OPopS) drug discovery platform. OPopS is a computer-aided technology that enables the rapid and low-cost synthesis of an array of carbohydrate-based compounds.
.
( Total: 13 Current Stock Recommendations )
Optimer Pharmaceuticals, Inc.   (13)
Sell 15% Hold 38% Buy 46%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
Heron Therapeutics ...   (7)
Buy 100%
CELSION CORP   (5)
Buy 100%
China Biologic ...   (3)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (4)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Oncogenex ...   (8)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
1/31/2008  
Buy
up  56.23 %
11/6/2008  
Buy
up  56.23 %
8/6/2009  
Buy
down  -10.37 %
9/21/2011  
Buy
down  -21.30 %
7/12/2012  
Buy
down  -14.85 %
9/18/2012  
Sell
up  14.51 %
9/19/2012  
Buy
down  -13.12 %
10/4/2012  
Sell
down  -0.70 %
10/9/2012  
None
down  -24.47 %
10/9/2012  
Hold
  
3/1/2013  
Hold
  
5/10/2013  
Hold
  
5/10/2013  
Hold
  
7/31/2013  
Hold
  

* As of 10/17/2014 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy